Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$594M |
| 2 |
Palo Alto Networks
PANW
|
+$592M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$463M |
| 4 |
Oracle
ORCL
|
+$454M |
| 5 |
Microsoft
MSFT
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$489M |
| 2 |
Intuit
INTU
|
+$408M |
| 3 |
HEICO Corp Class A
HEI.A
|
+$318M |
| 4 |
Yum China
YUMC
|
+$292M |
| 5 |
Stellantis
STLA
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Healthcare | 12.7% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Paysign
PAYS
$707M
| $40.9K | ﹤0.01% |
+16,674
| New | +$51.3K |
|
|
TGAN
3677
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $40.5K | ﹤0.01% |
11,914
+1,198
| +11% | +$4.32K |
|
3678
Ocugen
OCGN
$444M
| $39.8K | ﹤0.01% |
73,249
-3,367
| -4% | -$2.16K |
|
|
VRAY
3679
DELISTED
ViewRay, Inc.
VRAY
| $38.4K | ﹤0.01% |
109,133
+39,565
| +57% | +$41K |
|
3680
Trevi Therapeutics
TRVI
$2.54B
| $38.4K | ﹤0.01% |
+16,046
| New | +$40.4K |
|
|
KLRS
3681
Kalaris Therapeutics
KLRS
$93.7M
| $36.3K | ﹤0.01% |
465
-47
| -9% | -$4.47K |
|
|
ESPR
3682
DELISTED
Esperion Therapeutics
ESPR
| $36.1K | ﹤0.01% |
25,949
-4,265
| -14% | -$5.96K |
|
3683
Precigen
PGEN
$2.51B
| $36K | ﹤0.01% |
31,313
-99,759
| -76% | -$118K |
|
|
GTHX
3684
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $34.7K | ﹤0.01% |
13,925
+1,010
| +8% | +$2.76K |
|
|
AEVA
3685
Aeva Technologies
AEVA
$1.65B
| $34.2K | ﹤0.01% |
5,465
-1,417
| -21% | -$8.08K |
|
|
GRTX
3686
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $33.8K | ﹤0.01% |
+10,839
| New | +$32.2K |
|
3687
CytomX Therapeutics
CTMX
$750M
| $33.5K | ﹤0.01% |
19,458
+6,393
| +49% | +$10.6K |
|
|
KZR
3688
DELISTED
Kezar Life Sciences
KZR
| $32.8K | ﹤0.01% |
1,340
-246
| -16% | -$6.4K |
|
|
ADAP
3689
DELISTED
Adaptimmune Therapeutics
ADAP
| $32.4K | ﹤0.01% |
+34,992
| New | +$41.7K |
|
3690
BigBear.ai
BBAI
$1.55B
| $32.2K | ﹤0.01% |
+13,713
| New | +$34.8K |
|
3691
Denison Mines
DNN
$2.95B
| $31.2K | ﹤0.01% |
24,995
+499
| +2% | +$554 |
|
|
BGXX
3692
DELISTED
Bright Green Corporation Common Stock
BGXX
| $31.1K | ﹤0.01% |
+30,803
| New | +$33.3K |
|
3693
ProQR Therapeutics
PRQR
$255M
| $31K | ﹤0.01% |
+19,122
| New | +$37.3K |
|
|
LENZ
3694
LENZ Therapeutics
LENZ
$168M
| $30.6K | ﹤0.01% |
+1,679
| New | +$33.5K |
|
3695
Redwire
RDW
$3.13B
| $30.4K | ﹤0.01% |
11,907
-1,743
| -13% | -$4.75K |
|
3696
Akebia Therapeutics
AKBA
$234M
| $29.3K | ﹤0.01% |
+31,992
| New | +$30.9K |
|
|
CMRX
3697
DELISTED
Chimerix, Inc.
CMRX
| $29.2K | ﹤0.01% |
24,111
-20,303
| -46% | -$25.7K |
|
|
CDTX
3698
DELISTED
Cidara Therapeutics
CDTX
| $28.3K | ﹤0.01% |
+1,251
| New | +$29.4K |
|
|
AUTL
3699
Autolus Therapeutics
AUTL
$551M
| $25.5K | ﹤0.01% |
+10,699
| New | +$25.4K |
|
3700
Corvus Pharmaceuticals
CRVS
$1.16B
| $25.1K | ﹤0.01% |
+10,945
| New | +$22.7K |
|
Similar funds
Invesco's Q2 2023 Portfolio in Review
As of Q2 2023, Invesco held 4,050 positions worth $381B, up 6.4% from $358B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Invesco's Q2 2023 filing shows 175 new, 1,537 increased, 1,968 reduced and 189 closed positions. Its largest new stake was Full Truck Alliance: 18,396,172 shares worth $114M. The largest sale was Meta Platforms (Facebook), an estimated $489M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q2 2023 buy was Full Truck Alliance: 18,396,172 shares worth $114M.
- Invesco added most to Apple in Q2 2023, an estimated $594M increase.
- Invesco's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $489M.
- Invesco fully exited Stellantis in Q2 2023, selling an estimated $256M.
- Invesco's ten largest holdings make up 15% of its $381B portfolio in Q2 2023.
- Invesco opened 175 new positions and closed 189 in Q2 2023.
- Invesco's portfolio value rose 6.4% quarter-over-quarter to $381B.
Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.